MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Iron"

  • 2023 International Congress

    Huntingtonism and bilateral basal ganglia hypointensity in a male with an XK variant but no McLeod red cell phenotype

    J. Yu, R. Walker, A. Danek, C. Westhoff, S. Vege, I. Itin (Cleveland, USA)

    Objective: To report a novel variant of XK without the characteristic RBC phenotype Background: XK disease (previously called McLeod Syndrome) is a rare X-linked disorder…
  • 2023 International Congress

    Distinct deep grey matter iron accumulation in tremoric syndromes; an apparent quantitative susceptibility mapping mangetic resonance study

    A. Martín-Bastida, I. Aviles-Olmos, A. Gorospe-Osinalde, V. Suarez-Vega, P. Dominguez-Echavarri, R. García-Eulate, C. Sánchez-Catasús, MC. Rodríguez-Oroz (Pamplona, Spain)

    Objective: To investigate regional iron accumulation in patients with essential tremor (ET) and Parkinson´s disease (PD) and its clinical associations with apparent susceptibility-weighted imaging (SWI)…
  • 2023 International Congress

    Consideration of age and initial putaminal rim segment in distinguishing multiple system atrophy parkinsonian type

    W. Lee (Seoul, Republic of Korea)

    Objective: To improve diagnostic performance in distinguishing multiple system atrophy parkinsonian type (MSA-p), we investigated the iron deposition pattern in the putaminal lateral margin of…
  • 2023 International Congress

    Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

    B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)

    Objective: Assess the feasibility of detecting brain iron deposition using quantitative susceptibility mapping (QSM) among patients with Parkinson’s disease (PD) in a community-based clinic setting.…
  • 2022 International Congress

    Quantitative susceptibility mapping of basal ganglia and related structures: correlation with disease severity in Progressive Supranuclear Palsy

    S. Krishnan, S. George, S. Raghavan, B. Thomas, J. Thulaseedharan, D. Puthenveedu, A. Kishore (Thiruvananthapuram, India)

    Objective: We examined whether magnetic susceptibility estimates from deep gray matter structures in patients with Progressive Supranuclear Palsy (PSP) correlated with clinical measures of disease…
  • 2022 International Congress

    Apathy in Parkinson’s disease: serum biochemical markers and clinical features

    LT. Li, Y. Qu, HL. Gao, YJ. Xiong, Z. Min, ZJ. Mao, JY. Li, QX. Qin, DL. Wang, JW. Zhao, Z. Xue (Wuhan, China)

    Objective: This study aims to explore clinical features and blood biochemical markers of apathy in PD. Background: Apathy is one of the most common non-motor…
  • 2022 International Congress

    Epidemiological, clinical and paraclinical characteristics of metals accumulation in brain in childhood

    A. Atrous, H. Ben Rhouma, Z. Miladi, T. Ben Younes, H. Klaa, I. Kraoua, I. Benyoussef Turki (Ariana, Tunisia)

    Objective: The aim of our study is to describe epidemiological, clinical, and paraclinical characteristics of metals accumulation in brain in children. Background: Movement disorders can…
  • 2022 International Congress

    Using quantitative susceptibility mapping and diffusion magnetic resonance imaging to identify structural features of early-stage Parkinson’s disease

    E. Alushaj, D. Hemachandra, N. Handfield-Jones, A. Kuurstra, R. Menon, A. Owen, A. Khan, P. Macdonald (London, Canada)

    Objective: To identify an imaging diagnostic biomarker of PD for use in clinics by applying structural magnetic resonance imaging (MRI) techniques. Background: The midbrain dopaminergic…
  • MDS Virtual Congress 2020

    Quantitative susceptibility mapping images for the parcellation of the Subthalamic Nucleus: a possible role for targeting Deep Brain Stimulation

    E. Del Prete, P. Cecchi, D. Frosini, M. Costagli, S. Mazzucchi, G. Donatelli, G. Migaleddu, U. Bonuccelli, M. Cosottini, R. Ceravolo (Pisa, Italy)

    Objective: To investigate the iron distribution in STN in PD patients using QSM images. Background: Subthalamic Deep Brain Stimulation (DBS) is considered an effective treatment…
  • MDS Virtual Congress 2020

    Elevated nigral iron is associated with low plasma serotonin in Parkinson’s disease

    L. Jellen, A. Snyder, G. Du, M. Lewis, E. Wang, C. Capan, P. Brundin, L. Brundin, J. Connor, X. Huang (Hershey, PA, USA)

    Objective: The objective of this work was to determine whether plasma serotonin levels in Parkinson’s disease (PD) are related to iron levels in the brain,…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley